FDA approves Enhertu to treat a new subtype of breast cancer | Carrick Pharmacy

(Carrick Pharmacy News) The US Food and Drug Administration (FDA) approves a new breast cancer treatment. This approval is for Enhertu (fam-trastuzumab-deruxtecan-nxki).  It is approved to treat those with HER2-low breast cancer that is unable to be removed and has spread to other parts of the body Enhertu is the first treatment approved …

FDA approves Enhertu to treat a new subtype of breast cancer | Carrick Pharmacy Read More »